Detalles de la búsqueda
1.
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study.
BMC Cancer
; 22(1): 915, 2022 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35999527
2.
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study.
Oncologist
; 26(10): e1854-e1861, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34101934
3.
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations.
Br J Cancer
; 120(1): 57-62, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30377342
4.
Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer.
Future Oncol
; 14(4): 353-361, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29135281
5.
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.
Lancet Oncol
; 14(10): 981-8, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23883922
6.
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study).
Sci Rep
; 13(1): 1257, 2023 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36690734
7.
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences.
Eur J Cancer
; 174: 200-211, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36044814
8.
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.] / Gestione del paziente con microcitoma nelle regioni Lazio, Umbria e Sardegna.
Recenti Prog Med
; 112(10): 639-646, 2021 10.
Artículo
en Italiano
| MEDLINE | ID: mdl-34647533
9.
Molecular imaging in immuno-oncology: current status and translational perspectives.
Expert Rev Mol Diagn
; 20(12): 1199-1211, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33215963
10.
Long-term outcome of pemetrexed maintenance for advanced nonsquamous non-small-cell lung cancer: a real-world observational cohort study.
Recenti Prog Med
; 111(12): 761-768, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33362173
11.
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study.
Adv Ther
; 37(3): 1145-1155, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32002809
12.
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab.
Expert Opin Biol Ther
; 20(3): 319-326, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32011207
13.
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients.
Lung Cancer
; 140: 71-79, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31884129
14.
Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey.
Tumori
; 95(6): 647-51, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-20210223
15.
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology.
Transl Cancer Res
; 8(Suppl 1): S16-S22, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35117061
16.
Darbepoetin alfa administered every three weeks (Q3W) in anemic cancer patients receiving chemotherapy (CT).
Anticancer Res
; 28(3B): 1767-71, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18630457
17.
Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study.
Clin Lung Cancer
; 19(1): 93-104, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28645631
18.
Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma.
Tumori
; 93(2): 138-44, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17557559
19.
Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey.
Clin Lung Cancer
; 18(4): 381-387, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27965013
20.
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.
Lung Cancer
; 95: 73-81, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27040855